Nurtec (rimegepant) is not a controlled substance. It has no DEA schedule, carries no abuse potential, and is not regulated under the Controlled Substances Act. It is, however, a prescription medication, meaning you still need a doctor’s order to get it.
Why Nurtec Is Not Controlled
Before the FDA approved Nurtec in 2020, the agency’s Controlled Substance Staff conducted a formal review of its abuse potential. Their conclusion was unambiguous: rimegepant does not have abuse potential and should not be scheduled under the Controlled Substances Act.
Several lines of evidence supported that decision. Rimegepant does not bind to ion channels, transporters, or receptors in the brain that are associated with abuse potential. It is not structurally or mechanistically similar to any currently controlled substance. In animal studies, it did not produce the kinds of behaviors seen with known drugs of abuse. And across all human clinical trials, including tests at doses higher than the recommended amount, abuse-related side effects occurred in fewer than 0.5% of patients, a rate identical to placebo. No reports of euphoria were observed.
Because of this clean profile, the FDA did not even require a “Drug Abuse and Dependence” section on Nurtec’s prescribing label. That section is standard for medications with any meaningful risk of misuse.
How Nurtec Differs From Older Migraine Drugs
The question makes sense in context. Several medications commonly prescribed for migraine do carry controlled substance designations. Butalbital-containing drugs (like Fioricet in some states) are Schedule III. Benzodiazepines sometimes used for migraine-associated symptoms are Schedule IV. Opioids occasionally prescribed for severe migraine pain are Schedule II. These drugs all work on brain pathways tied to reward, sedation, or pain suppression, which creates real risks of dependence.
Nurtec works through an entirely different mechanism. It blocks a protein called CGRP (calcitonin gene-related peptide) at its receptor. CGRP levels spike during migraine attacks and play a central role in the pain signaling and blood vessel changes that drive migraine symptoms. By blocking CGRP from binding to its receptor, Nurtec interrupts the migraine process directly rather than masking pain through sedation or opioid pathways. This targeted approach is why it has no dependency risk.
What “Prescription Only” Means in Practice
Even though Nurtec is not a controlled substance, it still requires a prescription. These are two separate regulatory categories. A controlled substance has restrictions on refills, may require special prescribing licenses, and is tracked by state prescription drug monitoring programs. A standard prescription drug like Nurtec has none of those additional layers.
In practical terms, this means your doctor can prescribe Nurtec with refills, call it in to a pharmacy electronically or by phone, and you won’t encounter the tighter dispensing rules that apply to controlled medications. There are no federal limits on how many refills your doctor can authorize, and pharmacies are not required to report Nurtec prescriptions to state monitoring databases.
How Nurtec Is Taken
Nurtec is approved for two uses in adults: treating a migraine attack once it starts, and preventing migraine episodes before they happen. The dose is the same for both, 75 mg as an orally dissolving tablet, but the schedule differs.
For acute treatment, you take one 75 mg tablet as needed when a migraine begins. The maximum is one dose per 24 hours. For prevention of episodic migraine, you take one 75 mg tablet every other day on an ongoing basis. It is the only migraine medication currently approved for both acute and preventive use in a single formulation.
The tablet dissolves on your tongue without water, which is a practical advantage during a migraine when nausea can make swallowing pills difficult. You place it on or under your tongue and let it disintegrate, then swallow normally.
Side Effects to Be Aware Of
Because Nurtec targets a specific migraine pathway rather than broadly affecting the central nervous system, its side effect profile is relatively mild. It does not cause sedation, drowsiness, or the “foggy” feeling associated with some older migraine treatments. The most commonly reported side effect in clinical trials was nausea, and even that occurred at low rates. Allergic reactions, including difficulty breathing and rash, are possible but rare. Nurtec should be avoided if you have severe liver impairment, as the body relies on the liver to process the drug.